JPH05271282A - 環状主要hiv中和決定基とt細胞刺激エピトープとを含む合成ペプチド - Google Patents
環状主要hiv中和決定基とt細胞刺激エピトープとを含む合成ペプチドInfo
- Publication number
- JPH05271282A JPH05271282A JP4334729A JP33472992A JPH05271282A JP H05271282 A JPH05271282 A JP H05271282A JP 4334729 A JP4334729 A JP 4334729A JP 33472992 A JP33472992 A JP 33472992A JP H05271282 A JPH05271282 A JP H05271282A
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- gly
- amino acid
- seq
- hiv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/90—Fusion polypeptide containing a motif for post-translational modification
- C07K2319/92—Fusion polypeptide containing a motif for post-translational modification containing an intein ("protein splicing")domain
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81104191A | 1991-12-18 | 1991-12-18 | |
| US811041 | 1991-12-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH05271282A true JPH05271282A (ja) | 1993-10-19 |
Family
ID=25205379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4334729A Pending JPH05271282A (ja) | 1991-12-18 | 1992-12-15 | 環状主要hiv中和決定基とt細胞刺激エピトープとを含む合成ペプチド |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP0547689A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JPH05271282A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2085084A1 (cg-RX-API-DMAC7.html) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02211881A (ja) * | 1988-07-29 | 1990-08-23 | Inst Pasteur | HIVに対する中和抗体を誘発するかまたはかかる抗体によって認識され得る免疫原配列を含むHBsAg抗原の形態学的特徴を有する組換えハイブリッドHBsAg粒子、かかる粒子をコードするヌクレオチド配列及び核粒子を含むワクチン |
| JPH03172185A (ja) * | 1989-09-19 | 1991-07-25 | Merck & Co Inc | エイズ及びb型肝炎用のワクチン |
-
1992
- 1992-12-10 EP EP92203855A patent/EP0547689A2/en not_active Withdrawn
- 1992-12-10 CA CA002085084A patent/CA2085084A1/en not_active Abandoned
- 1992-12-15 JP JP4334729A patent/JPH05271282A/ja active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02211881A (ja) * | 1988-07-29 | 1990-08-23 | Inst Pasteur | HIVに対する中和抗体を誘発するかまたはかかる抗体によって認識され得る免疫原配列を含むHBsAg抗原の形態学的特徴を有する組換えハイブリッドHBsAg粒子、かかる粒子をコードするヌクレオチド配列及び核粒子を含むワクチン |
| JPH03172185A (ja) * | 1989-09-19 | 1991-07-25 | Merck & Co Inc | エイズ及びb型肝炎用のワクチン |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0547689A3 (cg-RX-API-DMAC7.html) | 1994-03-02 |
| CA2085084A1 (en) | 1993-06-19 |
| EP0547689A2 (en) | 1993-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5837249A (en) | Method for generating an immunogenic T cell response protective against a virus | |
| RU2201421C2 (ru) | Синтетический пептид hiv (варианты), иммуногенная композиция для индукции иммунного ответа против пептидов hiv, диагностический набор для определения hiv-специфичных антител | |
| US4983387A (en) | HIV related peptides, immunogenic antigens, and use therefor as subunit vaccine for AIDS virus | |
| AU570929B2 (en) | Broad spectrum influenza antisera | |
| AU650911B2 (en) | Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus | |
| EP0467700A2 (en) | Coconjugate vaccines comprising immunogenic protein, HIV related peptides, and anionic moieties | |
| JPH03128399A (ja) | エイズ用複合免疫原 | |
| IE871289L (en) | Peptides, antibodies, vaccines and assay methods. | |
| EP0468714A2 (en) | Peptide-polysaccharide-protein conjugate vaccines | |
| CA1271717A (en) | Polypeptides useful in vaccination against enteroviruses | |
| GB2282813A (en) | Annular antigen scaffolds comprising thioether linkages | |
| AU733234B2 (en) | Conjugated peptides, immunological reagent containing same and use thereof for treatment of immunological disorders | |
| US20090104220A1 (en) | Method to Make a Peptide-Carrier Conjugate with a High Immunogenicity | |
| KR100887591B1 (ko) | 특정의 교차 반응성을 증가시키는 항원성 구조들의 제조방법 | |
| EP0426314B1 (en) | HIV related peptides | |
| IE912534A1 (en) | Cyclic hiv principal neutralizing determinant peptides | |
| CA1280972C (en) | Complex immunogen containing synthetic peptides | |
| JPH05271282A (ja) | 環状主要hiv中和決定基とt細胞刺激エピトープとを含む合成ペプチド | |
| EP0498905A1 (en) | Conformational epitopes of human immunodeficiency virus envelope glycoprotein gp120 | |
| JPH05271276A (ja) | 環式hiv主要中和抗原決定基及びリポペプチドを含有する合成ペプチド | |
| JPH05170797A (ja) | 環状hiv主要中和決定基ペプチド | |
| HK1058154B (en) | Method for obtaining antigenic structures enhancing specific cross reactivity | |
| WO1992022579A1 (en) | MIMIC PEPTIDES OF gp120 |